Publications by authors named "David Starostka"

Claim this Profile
T
The utility of automated artificial intelligence-assisted digital cytomorphology for bone marrow analysis in diagnostic haemato-oncology.
David Starostka, Richard Dolezilek, Hans Michael Kvasnicka, Milos Kudelka, Petra Miczkova

Clin Transl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data.
Viera Sandecká, Luděk Pour, Ivan Špička, Jiří Minařík, Jakub Radocha, David Starostka

Eur J Haematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks.
Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova, David Starostka

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Anna Panovská, Lucie Němcová, Lucie Nekvindová, Martin Špaček, Martin Šimkovič, David Starostka

Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
David Starostka, Eva Kriegova, Milos Kudelka, Peter Mikula, Sarka Zehnalova

Cytometry B Clin Cytom· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
Viera Sandecká, Roman Hájek, Luděk Pour, Ivan Špička, Vlastimil Ščudla, David Starostka

Eur J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma Group.
Jiri Minarik, Viera Sandecka, Vladimir Maisnar, Evzen Gregora, Ivan Spicka, David Starostka

Leuk Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism G-308A in the promoter of the tumor necrosis factor-α gene and its association with the risk of venous thromboembolism.
Kristyna Horakova, Alicja Chylkova, Michal Kolorz, Ladislava Bartosova, Vaclav Pechacek, David Starostka

Blood Coagul Fibrinolysis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma.
Tomáš Papajík, Miroslav Mysliveček, Zuzana Sedová, Eva Buriánková, Vít Procházka, David Starostka

Clin Nucl Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
Vít Procházka, Tomás Papajík, Marie Jarosová, Zuzana Pikalová, Karel Indrák, David Starostka

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis